Goodwill and Other Intangible Assets	9 Months Ended
Goodwill and Other Intangible Assets	Sep. 30, 2022
Goodwill And Other Intangible Assets [Abstract]
Goodwill And Other Intangible Assets [Text Block]	Note 13 – Goodwill and Other Intangible Assets Changes in the carrying amount of goodwill for the nine months ended September 30, 2022 were as follows: Global Specialty Americas EMEA Asia/Pacific Businesses Total Balance as of December 31, 2021 $ 214,023 $ 135,520 $ 162,458 $ 119,193 $ 631,194 Goodwill additions (reductions) 1,853 — — (59) 1,794 Currency translation adjustments (810) (16,826) (16,462) (7,858) (41,956) Balance as of September 30, 2022 $ 215,066 $ 118,694 $ 145,996 $ 111,276 $ 591,032 Gross carrying amounts and accumulated amortization for definite-lived intangible assets as of September 30, 2022 and December 31, 2021 were as follows: Gross Carrying Accumulated Amount Amortization 2022 2021 2022 2021 Customer lists and rights to sell $ 803,346 $ 853,122 $ 173,893 $ 147,858 Trademarks, formulations and product technology 150,164 163,974 42,484 38,747 Other 6,611 6,309 5,973 5,900 Total definite-lived intangible assets $ 960,121 $ 1,023,405 $ 222,350 $ 192,505 The Company amortizes definite-lived intangible assets on a straight-line basis over their useful lives. The Company recorded $ 14.1 million and $ 43.3 million of amortization expense for the three and nine months ended September 30, 2022, respectively. Comparatively, the Company recorded $ 14.9 million and $ 44.7 million of amortization expense for the three and nine months ended September 30, 2021, respectively. Estimated annual aggregate amortization expense for the current year and subsequent five years and beyond is as follows: For the year ended December 31, 2022 $ 55,628 For the year ended December 31, 2023 55,454 For the year ended December 31, 2024 54,848 For the year ended December 31, 2025 54,027 For the year ended December 31, 2026 53,835 For the year ended December 31, 2027 and beyond 513,988 The Company had four indefinite-lived intangible assets totaling $ 178.2 million as of September 30, 2022, including $ 177.1 million of indefinite-lived intangible assets for trademarks and tradenames associated with the Combination. Comparatively, the Company had four indefinite-lived intangible assets for trademarks and tradenames totaling $ 196.9 million as of December 31, 2021. The Company completes its annual goodwill and indefinite-lived intangible asset impairment test during the fourth quarter of each year, or more frequently if triggering events indicate a possible impairment. The Company continually evaluates financial performance, economic conditions and other recent developments in assessing if a triggering event indicates that the carrying values of goodwill, indefinite-lived, or long-lived assets are impaired. The Company continues to monitor various financial, economic and geopolitical conditions impacting the Company, including the ongoing Russia-Ukraine war and the Company’s decision to cease operations in Russia, continued raw material cost escalation, supply chain constraints and disruptions, as well as rising interest rates and the cost of capital among other factors. The Company concluded that these and other factors, which have and continue to impact the Company, did not represent a triggering event during the third quarter of 2022, except for the Company’s EMEA reporting unit and the associated goodwill, as well as the related asset group. The Company concluded that during the third quarter of 2022 the escalation of these events adversely impacted EMEA’s financial performance and represented a triggering event. As a result of this conclusion, the Company completed an interim impairment assessment for its EMEA reporting unit, as well as the related asset group, during the third quarter of 2022. The Company concluded that the undiscounted cash flows exceeded the carrying value of the long-lived assets, and it is not more likely than not that an impairment exists. In completing a quantitative goodwill impairment test, the Company compares the reporting unit ’s fair value, primarily based on future discounted cash flows, to its carrying value in order to determine if an impairment charge is warranted. The estimates of future discounted cash flows involve considerable management judgment and are based upon certain significant assumptions including the weighted average cost of capital as well as projected EBITDA, which includes assumptions related to revenue growth rates, gross margin levels and operating expenses. As a result of this interim impairment assessment, the estimated fair value of the EMEA reporting unit exceeded its carrying value by approximately 22 % and the Company concluded no impairment was warranted. Notwithstanding the results of the Company’s interim impairment assessment, if the Company is unable to successfully implement selling price increases aimed at more than offsetting raw material costs and ongoing inflationary pressures and the financial performance of the EMEA reporting unit declines further, or interest rates continue to rise and this leads to an increase in the cost of capital, then it is possible these financial, economic and geopolitical conditions could result in another triggering event for the EMEA reporting unit in the future and could lead to a potential impairment . In addition, if any of these financial, economic or geopolitical conditions has a more significant adverse effect on the Company, these could lead to a potential impairment of the Company’s goodwill or other indefinite-lived or long-lived assets.